Livzon Pharmaceutical Group Inc. (1513) Releases Circular and Proxy Form for 2025 First Extraordinary General Meeting

Bulletin Express

Nov 10, 2025

On 11 November 2025, Livzon Pharmaceutical Group Inc. (Stock Code: 1513) announced the publication of its 2025 First Extraordinary General Meeting materials. These include a circular dated 11 November 2025, along with the meeting notice and proxy form, which are available on both the company’s website (www.livzon.com.cn) and The Stock Exchange of Hong Kong Limited’s website (www.hkexnews.hk).

The announcement states that shareholders who prefer receiving printed versions of these materials may complete and return the enclosed request form. Shareholders are also encouraged to provide a valid email address to ensure timely receipt of future corporate communications in electronic form.

To update contact details or request printed copies, shareholders can email 1513-ecom@vistra.com or send the completed request form to the company’s branch share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1122130638"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1122130638\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1122130638?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-10 19:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1122130638","market":"hk","top_or_hot":-1,"title":"Livzon Pharmaceutical Group Inc. (1513) Releases Circular and Proxy Form for 2025 First Extraordinary General Meeting","media":"Bulletin Express","content":"<p>On 11 November 2025, Livzon Pharmaceutical Group Inc. (Stock Code: 1513) announced the publication of its 2025 First Extraordinary General Meeting materials. These include a circular dated 11 November 2025, along with the meeting notice and proxy form, which are available on both the company’s website (www.livzon.com.cn) and The Stock Exchange of Hong Kong Limited’s website (www.hkexnews.hk).</p>\n<p>The announcement states that shareholders who prefer receiving printed versions of these materials may complete and return the enclosed request form. Shareholders are also encouraged to provide a valid email address to ensure timely receipt of future corporate communications in electronic form.</p>\n<p>To update contact details or request printed copies, shareholders can email 1513-ecom@vistra.com or send the completed request form to the company’s branch share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Livzon Pharmaceutical Group Inc. (1513) Releases Circular and Proxy Form for 2025 First Extraordinary General Meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLivzon Pharmaceutical Group Inc. (1513) Releases Circular and Proxy Form for 2025 First Extraordinary General Meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-10 19:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 11 November 2025, Livzon Pharmaceutical Group Inc. (Stock Code: 1513) announced the publication of its 2025 First Extraordinary General Meeting materials. These include a circular dated 11 November 2025, along with the meeting notice and proxy form, which are available on both the company’s website (www.livzon.com.cn) and The Stock Exchange of Hong Kong Limited’s website (www.hkexnews.hk).</p>\n<p>The announcement states that shareholders who prefer receiving printed versions of these materials may complete and return the enclosed request form. Shareholders are also encouraged to provide a valid email address to ensure timely receipt of future corporate communications in electronic form.</p>\n<p>To update contact details or request printed copies, shareholders can email 1513-ecom@vistra.com or send the completed request form to the company’s branch share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01513","symbol_name":"丽珠医药","start_time":0,"source_url":"","article_id":"1122130638","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122130638","pubTimestamp":1762773995,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 11 November 2025, Livzon Pharmaceutical Group Inc. (Stock Code: 1513) announced the publication of its 2025 First Extraordinary General Meeting materials. These include a circular dated 11...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01513":"丽珠医药"},"translate_title":"丽珠医药集团股份有限公司(1513)发布2025年第一次临时股东大会通函及代表委任表格","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01513":1},"content_text":"On 11 November 2025, Livzon Pharmaceutical Group Inc. (Stock Code: 1513) announced the publication of its 2025 First Extraordinary General Meeting materials. These include a circular dated 11 November 2025, along with the meeting notice and proxy form, which are available on both the company’s website (www.livzon.com.cn) and The Stock Exchange of Hong Kong Limited’s website (www.hkexnews.hk).\nThe announcement states that shareholders who prefer receiving printed versions of these materials may complete and return the enclosed request form. Shareholders are also encouraged to provide a valid email address to ensure timely receipt of future corporate communications in electronic form.\nTo update contact details or request printed copies, shareholders can email 1513-ecom@vistra.com or send the completed request form to the company’s branch share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}